News
The Diversity in Digital Health report zeroed in on the funding gap and the barriers that Black founders face in health tech.
NightWare's digital therapeutic monitors a wearer's heart rate and movement to detect disturbances during sleep, and delivers gentle vibrations to interrupt a nightmare without waking the user.
The Oakland, California, company recently announced collaborations with AstraZeneca and 3M Littmann Stethoscopes.
The platform has shared three studies presented at the 2020 North American Cystic Fibrosis (CF) conference.
During the pandemic, the company experienced rapid growth as both working parents and employers sought out benefits to help families thrive in and out of the workplace.
Flare Capital's Ian Chiang and Poorwa Godbole highlight the healthcare changes COVID-19 has already spurred and discuss why they're likely to stick around for the long haul.
The company attributed much of its success to growing smartwatch sales.
The company's lead offering for employer customers has so far reached more than 250,000 users.
The study, backed by the digital therapeutics company, measured the change in clinical encounter frequency among opioid use disorder patients who were also prescribed buprenorphine.
The drug delivery and packaging company will now have control over Cohero's FDA cleared spirometer, as well as its digital platforms and sensors.